Keratosis Pilaris Treatment Market 2027 By Modality, Treatment Type, Distribution Channel and Geography | The Insight Partners

Keratosis Pilaris Treatment Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Modality (Over the Counter, Prescription); Treatment Type (Topical Exfoliants, Topical Retinoids, Laser Treatments); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Geography

Report Code: TIPRE00013983 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

Keratosis pilaris is one of the common and harmless skin conditions that leads to rough and dry patches as well as tiny bumps that occurs on the thighs, upper arms, cheeks and buttocks. The bumps are usually painless and do not hurt. Moreover, the disease is often considered as one of the variant of normal skin. Medicated creams, topical ointments and therapies often help to improve the skin appearance.

MARKET DYNAMICS

The keratosis pilaris treatment market is likely to witness growth owing to factors such as increasing number of skin diseases worldwide, rising awareness among people regarding availability of treatment options and others. Furthermore, increasing trend of online pharmacies and ease of medicine availability is likely to offer growth opportunities over the years.

MARKET SCOPE

The "Keratosis Pilaris Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of keratosis pilaris treatment market with detailed market segmentation by modality, treatment type and distribution channel. The keratosis pilaris treatment market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in keratosis pilaris treatment market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The keratosis pilaris treatment market is segmented on the basis of modality, treatment type and distribution channel. Based on modality, the market is segmented as over-the-counter and prescription. On the basis of treatment type, the market is segmented into topical exfoliants, topical retinoids, and laser treatments. Based on distribution channel, the market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the keratosis pilaris treatment market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The keratosis pilaris treatment market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting keratosis pilaris treatment market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the keratosis pilaris treatment market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the keratosis pilaris treatment market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from keratosis pilaris treatment market are anticipated to have lucrative growth opportunities in the future with the rising demand for keratosis pilaris treatment in the global market. Below mentioned is the list of few companies engaged in the keratosis pilaris treatment market.

The report also includes the profiles of key players in keratosis pilaris treatment market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  Neostrata Company, INC.
  •  P and G
  •  SLMD Skincare
  •  Johnson & Johnson
  •  Galderma
  •  Touch Skin Care
  •  L'Oréal
  •  Novartis AG
  •  Beiersdorf AG
  •  Summit Medical Group

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Keratosis Pilaris Treatment Market - By Modality
1.3.2 Keratosis Pilaris Treatment Market - By Treatment Type
1.3.3 Keratosis Pilaris Treatment Market - By Distribution Channel
1.3.4 Keratosis Pilaris Treatment Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. KERATOSIS PILARIS TREATMENT MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. KERATOSIS PILARIS TREATMENT MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. KERATOSIS PILARIS TREATMENT MARKET - GLOBAL MARKET ANALYSIS
6.1. KERATOSIS PILARIS TREATMENT - GLOBAL MARKET OVERVIEW
6.2. KERATOSIS PILARIS TREATMENT - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. KERATOSIS PILARIS TREATMENT MARKET - REVENUE AND FORECASTS TO 2027 - MODALITY
7.1. OVERVIEW
7.2. MODALITY MARKET FORECASTS AND ANALYSIS
7.3. OVER THE COUNTER
7.3.1. Overview
7.3.2. Over the Counter Market Forecast and Analysis
7.4. PRESCRIPTION
7.4.1. Overview
7.4.2. Prescription Market Forecast and Analysis
8. KERATOSIS PILARIS TREATMENT MARKET - REVENUE AND FORECASTS TO 2027 - TREATMENT TYPE
8.1. OVERVIEW
8.2. TREATMENT TYPE MARKET FORECASTS AND ANALYSIS
8.3. TOPICAL EXFOLIANTS
8.3.1. Overview
8.3.2. Topical Exfoliants Market Forecast and Analysis
8.4. TOPICAL RETINOIDS
8.4.1. Overview
8.4.2. Topical Retinoids Market Forecast and Analysis
8.5. LASER TREATMENTS
8.5.1. Overview
8.5.2. Laser Treatments Market Forecast and Analysis
9. KERATOSIS PILARIS TREATMENT MARKET - REVENUE AND FORECASTS TO 2027 - DISTRIBUTION CHANNEL
9.1. OVERVIEW
9.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
9.3. HOSPITAL PHARMACIES
9.3.1. Overview
9.3.2. Hospital Pharmacies Market Forecast and Analysis
9.4. RETAIL PHARMACIES
9.4.1. Overview
9.4.2. Retail Pharmacies Market Forecast and Analysis
9.5. ONLINE PHARMACIES
9.5.1. Overview
9.5.2. Online Pharmacies Market Forecast and Analysis
10. KERATOSIS PILARIS TREATMENT MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Keratosis Pilaris Treatment Market Overview
10.1.2 North America Keratosis Pilaris Treatment Market Forecasts and Analysis
10.1.3 North America Keratosis Pilaris Treatment Market Forecasts and Analysis - By Modality
10.1.4 North America Keratosis Pilaris Treatment Market Forecasts and Analysis - By Treatment Type
10.1.5 North America Keratosis Pilaris Treatment Market Forecasts and Analysis - By Distribution Channel
10.1.6 North America Keratosis Pilaris Treatment Market Forecasts and Analysis - By Countries
10.1.6.1 United States Keratosis Pilaris Treatment Market
10.1.6.1.1 United States Keratosis Pilaris Treatment Market by Modality
10.1.6.1.2 United States Keratosis Pilaris Treatment Market by Treatment Type
10.1.6.1.3 United States Keratosis Pilaris Treatment Market by Distribution Channel
10.1.6.2 Canada Keratosis Pilaris Treatment Market
10.1.6.2.1 Canada Keratosis Pilaris Treatment Market by Modality
10.1.6.2.2 Canada Keratosis Pilaris Treatment Market by Treatment Type
10.1.6.2.3 Canada Keratosis Pilaris Treatment Market by Distribution Channel
10.1.6.3 Mexico Keratosis Pilaris Treatment Market
10.1.6.3.1 Mexico Keratosis Pilaris Treatment Market by Modality
10.1.6.3.2 Mexico Keratosis Pilaris Treatment Market by Treatment Type
10.1.6.3.3 Mexico Keratosis Pilaris Treatment Market by Distribution Channel
10.2. EUROPE
10.2.1 Europe Keratosis Pilaris Treatment Market Overview
10.2.2 Europe Keratosis Pilaris Treatment Market Forecasts and Analysis
10.2.3 Europe Keratosis Pilaris Treatment Market Forecasts and Analysis - By Modality
10.2.4 Europe Keratosis Pilaris Treatment Market Forecasts and Analysis - By Treatment Type
10.2.5 Europe Keratosis Pilaris Treatment Market Forecasts and Analysis - By Distribution Channel
10.2.6 Europe Keratosis Pilaris Treatment Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Keratosis Pilaris Treatment Market
10.2.6.1.1 Germany Keratosis Pilaris Treatment Market by Modality
10.2.6.1.2 Germany Keratosis Pilaris Treatment Market by Treatment Type
10.2.6.1.3 Germany Keratosis Pilaris Treatment Market by Distribution Channel
10.2.6.2 France Keratosis Pilaris Treatment Market
10.2.6.2.1 France Keratosis Pilaris Treatment Market by Modality
10.2.6.2.2 France Keratosis Pilaris Treatment Market by Treatment Type
10.2.6.2.3 France Keratosis Pilaris Treatment Market by Distribution Channel
10.2.6.3 Italy Keratosis Pilaris Treatment Market
10.2.6.3.1 Italy Keratosis Pilaris Treatment Market by Modality
10.2.6.3.2 Italy Keratosis Pilaris Treatment Market by Treatment Type
10.2.6.3.3 Italy Keratosis Pilaris Treatment Market by Distribution Channel
10.2.6.4 Spain Keratosis Pilaris Treatment Market
10.2.6.4.1 Spain Keratosis Pilaris Treatment Market by Modality
10.2.6.4.2 Spain Keratosis Pilaris Treatment Market by Treatment Type
10.2.6.4.3 Spain Keratosis Pilaris Treatment Market by Distribution Channel
10.2.6.5 United Kingdom Keratosis Pilaris Treatment Market
10.2.6.5.1 United Kingdom Keratosis Pilaris Treatment Market by Modality
10.2.6.5.2 United Kingdom Keratosis Pilaris Treatment Market by Treatment Type
10.2.6.5.3 United Kingdom Keratosis Pilaris Treatment Market by Distribution Channel
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Keratosis Pilaris Treatment Market Overview
10.3.2 Asia-Pacific Keratosis Pilaris Treatment Market Forecasts and Analysis
10.3.3 Asia-Pacific Keratosis Pilaris Treatment Market Forecasts and Analysis - By Modality
10.3.4 Asia-Pacific Keratosis Pilaris Treatment Market Forecasts and Analysis - By Treatment Type
10.3.5 Asia-Pacific Keratosis Pilaris Treatment Market Forecasts and Analysis - By Distribution Channel
10.3.6 Asia-Pacific Keratosis Pilaris Treatment Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Keratosis Pilaris Treatment Market
10.3.6.1.1 Australia Keratosis Pilaris Treatment Market by Modality
10.3.6.1.2 Australia Keratosis Pilaris Treatment Market by Treatment Type
10.3.6.1.3 Australia Keratosis Pilaris Treatment Market by Distribution Channel
10.3.6.2 China Keratosis Pilaris Treatment Market
10.3.6.2.1 China Keratosis Pilaris Treatment Market by Modality
10.3.6.2.2 China Keratosis Pilaris Treatment Market by Treatment Type
10.3.6.2.3 China Keratosis Pilaris Treatment Market by Distribution Channel
10.3.6.3 India Keratosis Pilaris Treatment Market
10.3.6.3.1 India Keratosis Pilaris Treatment Market by Modality
10.3.6.3.2 India Keratosis Pilaris Treatment Market by Treatment Type
10.3.6.3.3 India Keratosis Pilaris Treatment Market by Distribution Channel
10.3.6.4 Japan Keratosis Pilaris Treatment Market
10.3.6.4.1 Japan Keratosis Pilaris Treatment Market by Modality
10.3.6.4.2 Japan Keratosis Pilaris Treatment Market by Treatment Type
10.3.6.4.3 Japan Keratosis Pilaris Treatment Market by Distribution Channel
10.3.6.5 South Korea Keratosis Pilaris Treatment Market
10.3.6.5.1 South Korea Keratosis Pilaris Treatment Market by Modality
10.3.6.5.2 South Korea Keratosis Pilaris Treatment Market by Treatment Type
10.3.6.5.3 South Korea Keratosis Pilaris Treatment Market by Distribution Channel
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Keratosis Pilaris Treatment Market Overview
10.4.2 Middle East and Africa Keratosis Pilaris Treatment Market Forecasts and Analysis
10.4.3 Middle East and Africa Keratosis Pilaris Treatment Market Forecasts and Analysis - By Modality
10.4.4 Middle East and Africa Keratosis Pilaris Treatment Market Forecasts and Analysis - By Treatment Type
10.4.5 Middle East and Africa Keratosis Pilaris Treatment Market Forecasts and Analysis - By Distribution Channel
10.4.6 Middle East and Africa Keratosis Pilaris Treatment Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Keratosis Pilaris Treatment Market
10.4.6.1.1 South Africa Keratosis Pilaris Treatment Market by Modality
10.4.6.1.2 South Africa Keratosis Pilaris Treatment Market by Treatment Type
10.4.6.1.3 South Africa Keratosis Pilaris Treatment Market by Distribution Channel
10.4.6.2 Saudi Arabia Keratosis Pilaris Treatment Market
10.4.6.2.1 Saudi Arabia Keratosis Pilaris Treatment Market by Modality
10.4.6.2.2 Saudi Arabia Keratosis Pilaris Treatment Market by Treatment Type
10.4.6.2.3 Saudi Arabia Keratosis Pilaris Treatment Market by Distribution Channel
10.4.6.3 U.A.E Keratosis Pilaris Treatment Market
10.4.6.3.1 U.A.E Keratosis Pilaris Treatment Market by Modality
10.4.6.3.2 U.A.E Keratosis Pilaris Treatment Market by Treatment Type
10.4.6.3.3 U.A.E Keratosis Pilaris Treatment Market by Distribution Channel
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Keratosis Pilaris Treatment Market Overview
10.5.2 South and Central America Keratosis Pilaris Treatment Market Forecasts and Analysis
10.5.3 South and Central America Keratosis Pilaris Treatment Market Forecasts and Analysis - By Modality
10.5.4 South and Central America Keratosis Pilaris Treatment Market Forecasts and Analysis - By Treatment Type
10.5.5 South and Central America Keratosis Pilaris Treatment Market Forecasts and Analysis - By Distribution Channel
10.5.6 South and Central America Keratosis Pilaris Treatment Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Keratosis Pilaris Treatment Market
10.5.6.1.1 Brazil Keratosis Pilaris Treatment Market by Modality
10.5.6.1.2 Brazil Keratosis Pilaris Treatment Market by Treatment Type
10.5.6.1.3 Brazil Keratosis Pilaris Treatment Market by Distribution Channel
10.5.6.2 Argentina Keratosis Pilaris Treatment Market
10.5.6.2.1 Argentina Keratosis Pilaris Treatment Market by Modality
10.5.6.2.2 Argentina Keratosis Pilaris Treatment Market by Treatment Type
10.5.6.2.3 Argentina Keratosis Pilaris Treatment Market by Distribution Channel
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL KERATOSIS PILARIS TREATMENT MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Rest of the World
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. KERATOSIS PILARIS TREATMENT MARKET, KEY COMPANY PROFILES
13.1. NEOSTRATA COMPANY, INC.
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. P AND G
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. SLMD SKINCARE
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. JOHNSON AND JOHNSON
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. GALDERMA
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. TOUCH SKIN CARE
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. L'ORéAL
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. NOVARTIS AG
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. BEIERSDORF AG
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. SUMMIT MEDICAL GROUP
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies

1. Neostrata Company, INC.
2. P and G
3. SLMD Skincare
4. Johnson & Johnson
5. Galderma
6. Touch Skin Care
7. L'Oréal
8. Novartis AG
9. Beiersdorf AG
Summit Medical Group
TIPRE00013983
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking